Osteosarcoma: What did we learn from the paediatric experience for adolescents and young adults?

European Journal of Cancer, Supplement

Volumn 5, Issue 5, 2007, Pages 227-234

  Picci, Piero ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; IFOSFAMIDE; METHOTREXATE;

ADOLESCENT; ADULT; AMPUTATION; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; CENTRAL NERVOUS SYSTEM TUMOR; COLON CANCER; DRUG MEGADOSE; HUMAN; LEUKEMIA; LIMB SALVAGE; LUNG CANCER; LUNG METASTASIS; OSTEOSARCOMA; PAROTID GLAND CANCER; PRIORITY JOURNAL; SECOND CANCER; SOFT TISSUE SARCOMA;

EID: 35548957357     PISSN: 13596349     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6349(07)70044-7     Document Type: Article

References (52)

1. Schajowicz F., Sissons H., and Sobin L. The World Health Organization's histologic classification of bone tumors. A commentary on the second edition. Cancer 75 5 (1995) 1208-1214
2. Gross S. The Classic: sarcoma of the long bones: based upon a study of one hundred and sixty-five cases. 1879. Clin Orthop Relat Res 438 (2005) 9-14
3. Campanacci M., Bacci G., Bertoni F., Picci P., Minutillo A., and Franceschi C. The treatment of osteosarcoma of the extremities: twenty year's experience at the Istituto Ortopedico Rizzoli. Cancer 48 7 (1981) 1569-1581
4. Uribe-Botero G., Russell W., Sutow W., and Martin R. Primary osteosarcoma of bone. Clinicopathologic investigation of 243 cases, with necropsy studies in 54. Am J Clin Pathol 67 5 (1977) 427-435
5. Marcove R., Mike V., Hajek J., Levin A., and Hutter R. Osteogenic sarcoma under the age of twenty-one. A review of one hundred and forty-five operative cases. J Bone Joint Surg Am 52 3 (1970) 411-423
6. Taylor W., Ivins I., Dahlin D., Edmonson J., and Pritchard D. Trends and variability in survival from osteosarcoma. Mayo Clinic Proc 53 (1978) 695-700
7. Picci P., Calderoni P., Cagnano R., Minutillo A., Gherlinzoni F., and Bacci G. The hypothetical change in the natural history of osteosarcoma. Chemioterapia 1 (1982) 420-426
8. Link M., Goorin A., Miser A., et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med 314 25 (1986) 1600-1606
9. Eilber F., Giuliano A., Eckardt J., Patterson K., Moseley S., and Goodnight J. Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. J Clin Oncol 5 1 (1987) 21-26
10. Lee E., Mackenzie D., and Osteosarcoma. A study of the value of preoperative megavoltage radiotherapy. Br J Surg 51 (1964) 252-274
11. Francis K., Phillips R., Nickson J., Woodard H., Higinbotham N., and Coley B. Massive preoperative irradiation in the treatment of osteogenic sarcoma in children; a preliminary report. Am J Roentgenol Radium Ther Nucl Med 72 5 (1954) 813-818
12. Jenkin R., Allt W., and Fitzpatrick P. Osteosarcoma. An assessment of management with particular reference to primary irradiation and selective delayed amputation. Cancer 30 2 (1972) 393-400
13. Cortes E., Holland J., Wang J., et al. Doxorubicin in disseminated osteosarcoma. JAMA 221 (1972) 1132-1138
14. Jaffe N. Recent advances in the chemotherapy of metastatic osteogenic sarcoma. Cancer 30 6 (1972) 1627-1631
15. Cortes E., Holland J., Wang J., et al. Amputation and adriamycin in primary osteosarcoma. N Engl J Med 291 19 (1974) 998-1000
16. Jaffe N., Frei III E., Traggis D., and Bishop Y. Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma. N Engl J Med 291 19 (1974) 994-997
17. Bacci G., Longhi A., Fagioli F., Briccoli A., Versari M., and Picci P. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy. Eur J Cancer 41 18 (2005) 2836-2845
18. Gasparini M., Tondini C., Azzarelli A., and Fossati-Bellani F. Long- term evaluation of surgery followed by adjuvant adriamycin in osteogenic sarcoma. Eur J Cancer Clin Oncol 23 4 (1987) 433-436
19. Spanier S., Shuster J., and Vander Griend R. The effect of local extent of the tumor on prognosis in osteosarcoma. J Bone Joint Surg Am 72 5 (1990) 643-653
20. Rosenburg S., Chabner B., Young R., et al. Treatment of osteogenic sarcoma. I. Effect of adjuvant high-dose methotrexate after amputation. Cancer Treat Rep 63 5 (1979) 739-751
21. Goorin A., Perez-Atayde A., Gebhardt M., et al. Weekly high- dose methotrexate and doxorubicin for osteosarcoma: the Dana- Farber Cancer Institute/the Children's Hospital - study III. J Clin Oncol 5 8 (1987) 1178-1184
22. Winkler K., Beron G., Schellong G., et al. Cooperative osteosarcoma study COSS-77: results after 4 years. Klin Padiatr 194 4 (1982) 251-256
23. Rosen G., Tan C., Sanmaneechai A., Beattie Jr. E., Marcove R., and Murphy M. The rationale for multiple drug chemotherapy in the treatment of osteogenic sarcoma. Cancer 35 suppl 3 (1975) 936-945
24. Rosen G., and Nirenberg A. Neoadjuvant chemotherapy for osteogenic sarcoma: a five year follow-up (T-10) and preliminary report of new studies (T-12). Prog Clin Biol Res 201 (1985) 39-51
25. Hausdorf G., Morf G., Beron G., et al. Long term doxorubicin cardiotoxicity in childhood: non-invasive evaluation of the contractile state and diastolic filling. Br Heart J 60 4 (1988) 309-315
26. Winkler K., Beron G., Delling G., et al. Neoadjuvant chemotherapy of osteosarcoma results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 6 (1988) 329-337
27. Bramwell V., Burgers M., Sneath R., et al. A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup. J Clin Oncol 10 10 (1992) 1579-1591
28. Benjamin R. Regional chemotherapy for osteosarcoma. Semin, Oncol 16 4 (1989) 323-327
29. Provisor A., Ettinger L., Nachman J., et al. Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group. J Clin Oncol 15 1 (1997) 76-84
30. Smeland S., Wiebe T., Bohling T., Brosjo O., Jonsson K., and Alvegard T. Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience. Acta Orthop Scand 75 311 (2004) 92-98 Suppl
31. Fuchs N., Bielack S., Epler D., et al. Long-term results of the co- operative German-Austrian-Swiss osteosarcoma study group's protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 9 8 (1998) 893-899
32. Kalifa C., Razafindrakoto H., Vassal G., et al. Cemotherapy in osteogenic sarcoma: the experience of the Pediatric Department of the Gustave Roussy Institute. Cancer Treat Res 62 (1993) 347-349
33. Souhami R., Craft A., Van der Eijken J., et al. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet 350 9082 (1997 Sep) 911-917
34. Goorin A., Schwartzentruber D., Devidas M., et al. Pediatric Oncology Group. Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651. J Clin Oncol 21 8 (2003) 1574-1580
35. Bacci G., Longhi A., Versari M., Mercuri M., Briccoli A., and Picci P. Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer 106 5 (2006) 1154-1161
36. Longhi A., Errani C., De Paolis M., Mercuri M., and Bacci G. Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev 32 6 (2006) 423-436
37. Picci P., Sangiorgi L., Rougraff B., Neff J., Casadei R., and Campanacci M. Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma. J Clin Oncol 12 12 (1994) 2699-2705
38. Bacci G., Mercuri M., Longhi A., Setola E., Gozzi E., and Forni C. Neoadjuvant chemotherapy for the treatment of osteosarcoma of the extremities: a comparison of results obtained in single- institution and multicenter trials. Chir Organi Mov 89 4 (2004) 283-292
39. Bacci G., Longhi A., Cesari M., Versari M., and Bertoni F. Influence of local recurrence on survival in patients with extremity osteosarcoma treated with neoadjuvant chemotherapy: the experience of a single institution with 44 patients. Cancer 106 12 (2006) 2701-2706
40. Sutow W., Gehan E., Vietti T., Frias A., and Dyment P. Multidrug chemotherapy in pulmonary treatment of osteosarcoma. J Bone Joint Surg Am 58 5 (1976) 629-633
41. Goorin A., Chauvenet A., Perez-Atayde A., Cruz J., McKone R., and Lipshultz S. Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer. J Pediatr 116 1 (1990) 144-147
42. Longhi A., Macchiagodena M., Vitali G., and Bacci G. Fertility in male patients treated with neoadjuvant chemotherapy for osteosarcoma. J Pediatr Hematol Oncol 25 4 (2003) 292-296
43. Bacci G., Ferrari C., Longhi A., et al. Second malignant neoplasm in patients with osteosarcoma of the extremities treated with adjuvant and neoadjuvant chemotherapy. J Pediatr Hematol Oncol 28 12 (2006) 774-780
44. Meyers P., Heller G., Healey J., et al. Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol 11 3 (1993) 449-453
45. Beron G., Euler A., and Winkler K. Pulmonary metastases from osteosarcoma: complete resection and effective chemotherapy contribuiting to improved prognosis. Paediatr Hematol Oncol 2 (1985) 425-431
46. Kaste S., Pratt C., Cain A., Jones-Wallace D., and Rao B. Metastases detected at the time of diagnosis of primary pediatric extremity osteosarcoma at diagnosis: imaging features. Cancer 86 8 (1999) 1602-1608
47. Marina N., Pratt C., Rao B., Shema S., and Meyer W. Improved prognosis of children with osteosarcoma metastatic to the lung(s) at the time of diagnosis. Cancer 70 11 (1992) 2722-2727 Erratum in:
48. Cancer 71 9 (1993) 2879
49. Thompson Jr. R., Cheng E., Clohisy D., Perentesis J., Manivel C., and Le C. Results of treatment for metastatic osteosarcoma with neoadjuvant chemotherapy and surgery. Clin Orthop Relat Res 397 (2002) 240-247
50. Mialou V., Philip T., Kalifa C., et al. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome-the French pediatric experience. Cancer 104 5 (2005) 1100-1109
51. Harris M., Gieser P., Goorin A., et al. Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study. J Clin Oncol 16 11 (1998) 3641-3648
52. Bacci G., Fabbri N., Balladelli A., Forni C., Palmerini E., and Picci P. Treatment and prognosis for synchronous multifocal osteosarcoma in 42 patients. J Bone Joint Surg Br 88 8 (2006) 1071-1075